Ultrastructural definition of apoptosis in heart failure

Heart Failure Reviews

Volumn 13, Issue 2, 2008, Pages 121-135

  Arbustini, Eloisa ^a   Brega, Agnese ^b,c   Narula, Jagat ^d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Autophagocytosis; Electron microscopy; Heart failure; Oncosis

Indexed keywords

CRYSTALLIN; CYTOCHROME C; DESMIN; DYSTROPHIN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; LAMIN; LIPOCORTIN 5; LIPOFUSCIN; MITOCHONDRIAL DNA;

ANTIBODY LABELING; APOPTOSIS; ARTICLE; AUTOPHAGY; BARTH SYNDROME; CELL DEATH; CELL ULTRASTRUCTURE; CELL VIABILITY; CONGESTIVE CARDIOMYOPATHY; ELECTRON MICROSCOPY; GENE MUTATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOELECTRON MICROSCOPY; MACROPHAGE FUNCTION; MITOCHONDRIAL DNA DISORDER; NICK END LABELING; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; AUTOPHAGY; HEART FAILURE; HUMANS; MICROSCOPY, ELECTRON; MYOCYTES, CARDIAC;

EID: 41249092847     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-007-9072-8     Document Type: Article

References (90)

1. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, Hayakawa Y, Zimmermann R, Bauer E, Klovekorn WP, Schaper J (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92:715-724
2. Kunapuli S, Rosanio S, Schwarz ER (2006) How do cardiomyocytes die?" apoptosis and autophagic cell death in cardiac myocytes. J Card Fail 12:381-391
3. Takemura G, Fujiwara H (2006) Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10:56-75
4. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15
5. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Minatoguchi S, Fujiwara H (1999) Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 99:2757-2764
6. Bartunek J, Vanderheyden M, Knaapen MW, Tack W, Kockx MM, Goethals M (2002) Deoxyribonucleic acid damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40:1097-1103
7. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
8. Danial NN, Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116:205-219
9. Cheng G, Wessels A, Gourdien RG, Thompson RP (2002) Spatiotemporal and tissue specific distribution of apoptosis in the developing chick heart. Dev Dynam 223:119-133
10. Su TT (2000) The regulation of cell growth and proliferation during organogenesis. In Vivo 14:141-148
11. Henso PM, Hume DA (2006) Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 27:244-250
12. Mallat Z, Fornes P, Costagliola R, Esposito B, Belmin J, Lecompte D, Tedgui A (2001) Age an gender effects on cardiomyocyte apoptosis in the normal human heart. J Geront A: Biol Sci Med Sci 56:M719-M723
13. Debatin KM, Krammer PH (2004) Death receptors in chemotherapy and cancer. Oncogene 23:2950-2966
14. Moretti L, Cha YI, Niermann KJ, Lu B (2007) Switch between apoptosis and autophagy: Radiation-induced endoplasmic reticulum stress? Cell Cycle 6:793-798
15. Nguyen ML, Blaho JA (2007) Apoptosis during herpes simplex virus infection. Adv Virus Res 69:67-97
16. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621-1628
17. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K (1995) DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146:1325-1331
18. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P (1995) Stretch induced programmmed cell death. J Clin Invest 96:2247-2259
19. Grazette LP, Rosenzweig A (2005) Role of apoptosis in heart failure. Heart Fail Clin 1:251-261
20. Narula J, Haider N, Arbustini E, Chandrashekhar Y (2006) Mechanisms of disease: Apoptosis in heart failure-seeing hope in death. Nature Clin Pract Cardiovasc Med 3:681-688
21. Narula J, Arbustini E, Chandrashekhar Y, Schwaiger M (2001) Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 19:113-126
22. Hunter AL, Choy JC, Granville DJ (2005) Detection of apoptosis in cardiovascular diseases. Methods Mol Med 112:277-289
23. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
24. Van Heerde WL, Robert-Offerman S, Dumont E, Hofstra R, Doevendans PA, Smits JF, Daemen MJ, Reuteligsperger CP (2000) Markers of apoptosis in cardiovascular tissues: Focus on Annexin V. Cardiovasc Res 45:549-559
25. Jans SW, van Bilsen M, Reutelingsperger CP, Borgers M, de Jong YF, van der Vusse GJ (1995) Annexin V in the adult rat heart: Isolation, localization and quantitation. J Mol Cell Cardiol 27:335-348
26. Zaunreiter M, Brandstatter R, Donato R, Hermann A (2005) Localization of annexins in the retina of the rainbow trout-light and electron microscopical investigations. Brain Res 1032:1-10
27. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96:8144-8149
28. McCarty NJ, Evan GJ (1998) Methods for detecting and quantifying apoptosis. Curr Top Dev Biol 36:259-278
29. Savill J, Fadok V (2000) Corpes clearing defines the meaning of cell death. Nature 407:784-788
30. 99mTc-labeled annexin A5 in heart failure. J Nucl Med 48:562-567
31. Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S, Rossettin P, Ghigliotti G, Ballestrero A, Patrone F, Barsotti A, Brunelli C (2004) Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocites in vitro. J Mol Cell Cardiol 37:837-846
32. Rivard AL, Steer CJ, Kren BT, Rodrigues CM, Castro RE, Bianco RW, Low WC (2007) Administration of Tauroursodeoxycholic Acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Clin Med 35:279-295
33. Dong Z, Saikumar P, Weiberg JM, Venkatachalam MA (1997) Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol 151:1205-1213
34. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, Fujiwara T, Fujiwara H (1998) Apoptotic myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation 98:1422-1430
35. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890-898
36. Maderna P, Godson C (2003) Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 1639:141-151
37. Ogden CA, Elkon KB (2006) Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr Dir Autoimmun 9:120-142
38. Takashi E, Ashraf M (2000) Pathologic assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J Mol Cell Cardiol 32:209-224
39. Waller BF (1988) The pathology of acute myocardial infarction: definition, location, pathogenesis, effect of reperfusion, complications, and sequelae. Cardiol Clin 6:1-28
40. Jugdutt BI, Idikio HA (2005) Apoptosis and oncosis in acute coronary syndromes: Assessment and implications. Mol Cell Biochem 270:177-200
41. Goldsten MA (1979) Ultrastructure of the ischemic myocardium. Cardiovasc Res Cent Bull 18:1-33
42. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B (2003) Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301:1387-1391
43. Stromhaug PE, Klionsky DJ (2001) Approaching the molecular mechanism of autophagy. Traffic 2:524-531
44. Otto GP, Wu MY, Kazgan N, Anderson OR, Kessin RH (2003) Macroautophagy is required for multicellular development of the social amoeba Dictyostelium discoideum. J Biol Chem 16(278):17636-17645
45. Huang WP, Klionsky DJ (2002) Autophagy in yeast: A review of the molecular machinery. Cell Struct Funct 27:409-420
46. Suzuki K, Ohsumi Y (2007) Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 581:2156-2161
47. Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290:1717-1721
48. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: A double-edged sword. Science 306:990-995
49. Depre C, Kim SJ, John AS, Huang Y, Rimoldi OE, Pepper JR, Dreyfus GD, Gaussin V, Pennel DJ, Vatner DE, Camici PG, Vatner SF (2004) Program of cell survival underlying human and experimental hibernating myocardium. Circ Res 95:433-440
50. Kim SJ, Depre C, Vatner SF (2003) Novel mechanisms mediating stunned myocardium. Heart Fail Rev 8:143-153
51. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Matsui GJJ, Sadoshima J, Vatner SF (2005) Autophagy in chronically ischemic myocardium. PNAS 102:13807-13812
52. Hamacher-Brady A, Brady NR, Gottlieb RA (2006) The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/ reperfusion injury: Apoptosis meets autopagy. Cardiovasc Drugs Ther 20:445-462
53. Casey TM, Arthur PG, Bogoyevitch MA (2007) Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stress. Biochim Biophys Acta 1773:342-351
54. Sperandio S, de Belle I, Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97:14376-14381
55. Terman A, Brunk UT (1998) Lipofuscin: Mechanisms of formation and increase with age. APMIS 106:265-276
56. Spoerri PE. Glees P, El Ghazzawi E (1974) Accumulation of lipofuscin in the myocardium of senile guinea pigs: Dissolution and removal of lipofuscin following dimethylaminoethyl p-chlorophenoxyacetate administration. An electron microscopic study. Mech Ageing Dev 3:311-321
57. Grune T. Reinheckel T, Davies KJ (1997) Degradation of oxidized proteins in mammalian cells. FASEB J 11:526-534
58. Terman A, Brunk UT (2005) The aging myocardium: Roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ 14:107-114
59. Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJ, Katzeff H (2005) Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38:1093-1101
60. Arbustini E, Diegoli M, Morbini P, Dal Bello B, Banchieri N, Pilotto A, Magani F, Grasso M, Narula J, Gavazzi A, Vigano M, Tavazzi L (2000) Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35:1760-1768
61. Deconinck N, Dan B (2007) Pathophysiology of duchenne muscular dystrophy: Current hypotheses. Pediatr Neurol 36:1-7
62. Tews DS (2006) Characterization of initiator and effector caspase expressions in dystrophinopathies. Neuropathology 26:24-31
63. Kumar A, Boriek AM (2003) Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: A possible role in Duchenne muscular dystrophy. FASEB J 17:386-396
64. Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T (1999) Sarcoglycan complex: A muscular supporter of dystroglycan-dystrophin interplay? Cell Mol Biol 45:751-762
65. Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA (2000) Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. Clin Invest 106:655-662
66. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142:1279-1287
67. OMIM: http://www.ncbi.nlm.nih.gov/
68. Meaburn KJ, Cabuy E, Bonne G, Levy N, Morris GE, Novelli G, Kill IR, Bridger JM (2007) Primary laminopathy fibroblasts display altered genome organization and apoptosis. Ageing Cell 6:139-153
69. Rao L, Perez D, White E (1996) Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135:1441-1455
70. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT (2004) Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370-378
71. Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L (2002) Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease. J Am Coll Cardiol 39:981-990
72. Verga L, Concardi M, Pilotto A, Bellini O, Pasotti M, Repetto A, Tavazzi L, Arbustini E (2003) Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects. Virchows Arch 443:664-671
73. Wallace DC (2000) Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J 139:S70-S85
74. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482-1488
75. Schapira AH (2006) Mitochondrial disease. Lancet 368:70-82
76. Brega A, Narula J, Arbustini E (2001) Functional, structural and genetic mitochondrial abnormalities in myocardial diseases. J Nuclear Cardiol 8:89-97
77. Arnheim N, Cortopassi G (1992) Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 275:157-167
78. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC (1991) Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. J Am Med Assoc 266:1812-1816
79. Cortopassi GA, Shibata D, Soong NW, Arnheim N (1992) A pattern of Accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. PNAS 89:7370-7374
80. Ito T, Hattori K, Obayashi T, Tanaka M, Sugiyama S, Ozawa T (1992) Mitochondrial DNA mutations in cardiomyopathy. Jpn Circ J 56:1045-1053
81. Wallace DC (1992) Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212
82. Zhang D, Mott JL, Farrar P, Ryerse JS, Chang SW, Stevens M, Denniger G, Zassenhaus HP (2003) Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy. Cardiovas Res 57:147-157
83. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, Vigano M (1998) Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153:1501-1510
84. Maloyan A, Sanbe A, Osinska H, Westfall M, Robinson D, Imahashi K, Murphy E, Robbins J (2005) Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 112:3451-3461
85. Barth PG, Scholte HR, Berden JA, Van Der Klei-Van Moorsel JM, Luyt-Houwen IEM, Van'T Veer-Korthof ETH, Van Der Harten JJ, Sobotka-Plojhar MA (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle, and neutrophil leukocytes. J Neurol Sci 62:327-355
86. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12:385-389
87. Kuijpers TW, Maianski NA, Tool AT, Becker K, Plecko B, Valianpour F, Wanders RJ, Pereira R, Van Hove J, Verhoeven AJ, Roos D, Baas F, Barth PG (2004) Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 103:3915-3923
88. Maron BJ (2002) Hypertrophic cardiomyopathy: A systematic review. JAMA 13:1308-1320
89. Ino T, Nishimoto K, Okubo M, Akimoto K, Yabuta K, Kawai S, Okada R, Sueyoshi N (1997) Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol 79:1137-1141
90. Koda M, Takemura G, Kanoh M, Hayakawa K, Kawase Y, Maruyama R, Li Y, Minatoguchi S, Fujiwara T, Fujiwara H (2003) Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: A manifestation of cardiac hypertrophy rather than failure. J Pathol 199:229-236